167
Views
3
CrossRef citations to date
0
Altmetric
Letters to the Editor

Anti CD20-based immunochemotherapy abolishes antibody response to Covid-19 mRNA vaccine in lymphoma patients vaccinated during active first line treatment

ORCID Icon, , , , , ORCID Icon, , ORCID Icon, , ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 1474-1478 | Received 22 Oct 2021, Accepted 14 Jan 2022, Published online: 01 Feb 2022
 

Author contributions

SB, SM, EM and SH designed the research study, performed research, analyzed data and wrote paper, MPB, IP and FDM performed serological tests, FF performed flow cytometric analysis, EA, MV and FD collected clinical data, VDS and MS performed critical revision of the article. All authors approved the final manuscript.

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

SH acknowledges research funding by a grant from the Italian Ministry of Education, Universities and Research (MIUR): PRIN Prot. 2017 PPS2X4.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.